Halma snatches up MicroSurgical Technology for $57M; EndoStim raises $8M;

 @FierceMedDev: St. Jude faces escalation of shareholder lawsuits over Durata leads. Article | Follow @FierceMedDev

@MarkHFierce: Nanostim says it successfully implanted leadless cardiac pacers into 11 patients in the Czech Republic. Major progress. News | Follow @MarkHFierce

 @DamianFierce:  Critical Diagnostics has inked distribution deals for its heart test with Quest ($DGX) and LabCorp ($LH). More | Follow @DamianFierce

> Medical device startup EndoStim raised more than $8 million of a total $12 million fundraising round. Story

> Chembio Diagnostics won FDA approval for its new HIV oral fluid or blood sample diagnostic test, and investors drove the stock up to a new high for the year. Item

> Expect more congressional scrutiny and FDA recalls in 2013, a new report concludes. Item

> The device tax isn't the only reason that 2013 will be a struggle for medical device companies. Story

> In vitro diagnostics company Venaxis has appointed a Beckman Coulter executive to its board of directors. Item

> Halma, a maker of various health technologies in the U.K., is snatching up ophthalmic surgical products company MicroSurgical Technology for at least $57 million. Story

Biotech News

 @FierceBiotech: Add a drop of blood, and this tiny Dx device tests 50 things at once. Story | Follow @FierceBiotech

@JohnCFierce: Halozyme gets $8M upfront and a bunch of potential biobucks in drug delivery collab with Pfizer. Release | Follow @JohnCFierce

@RyanMFierce: Halozyme rebounds with $8M Pfizer biologics pact. More | Follow @RyanMFierce

> Transcept caps a tough year with PhII drug failure. Article

> Merck's big PhIII failure on cholesterol drug spurs an EMA review. Report

> Raptor gets $50M loan to back launch of rare disease drug. News

> Karolinska Development inks a $33M deal on a batch of its projects. Story

Pharma News

@FiercePharma: Smaller players looking for expansion deals, too. News | Follow @FiercePharma

> Sanofi animal health deal puts it in India. More

> India vaccine makers see China undercutting them. Story

> EMA having second thoughts about Merck's Tredaptive. Item